B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells.
Zhou H, Yu C, Kong L, Xu X, Yan J, Li Y, An T, Gong L, Gong Y, Zhu H, Zhang H, Yang X, Li Y.
Zhou H, et al. Among authors: li y.
Oncogene. 2019 May;38(18):3371-3386. doi: 10.1038/s41388-018-0674-5. Epub 2019 Jan 11.
Oncogene. 2019.
PMID: 30635656
Free PMC article.